Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Onset of glaucoma may be delayed with treatment of IOP
Investigators from 22 clinical centers across the country have discovered that eye drops used to treat elevated IOP can be effective in delaying the onset of glaucoma, according to the recently released results of the Ocular Hypertension Treatment Study (OHTS).
Related Videos
Related Content
